Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Struct Biol. 1997 Nov;4(11):947-52.

Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 A resolution.

Author information

  • 1Systèmes Moléculaires et Biologie Structurale, CNRS URA09, Université Paris VI et Paris VII, France.

Abstract

The gene coding for urate oxidase, an enzyme that catalyzes the oxidation of uric acid to allantoin, is inactivated in humans. Consequently, urate oxidase is used as a protein drug to overcome severe disorders induced by uric acid accumulation. The structure of the active homotetrameric enzyme reveals the existence of a small architectural domain that we call T-fold (for tunnelling-fold) domain. It assembles to form a perfect unusual dimeric alpha 8 beta 16 barrel. Urate oxidase may be the archetype of an expanding new family of tunnel-shaped proteins that now has three members; tetrahydropterin synthase, GTP cyclohydrolase I and urate oxidase. The structure of the active site of urate oxidase around the 8-azaxanthine inhibitor reveals an original mechanism of oxidation that does not require any ions or prosthetic groups.

PMID:
9360612
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk